期刊文献+

盐酸吡咯列酮固体分散体的制备及体外溶出度研究

Research on the preparation and dissolution rate of the solid dispersion of pioglitazone hydrochloride
下载PDF
导出
摘要 目的:采用冷冻干燥法制盐酸吡格列酮(Pioglitazone Hydrochloride,PGH)速释固体分散体(SD)来提高其体外溶出度。方法:将PGH与载体及酸性调节剂制备成固体分散体,通过测定药物的体外溶出度,来选择最优辅料及比例,结果:当以羟丙甲基纤维素(HPMC)为载体,酒石酸(TA)为酸性调节剂,且PGH:HPMC:TA=1:1:10%时药物呈现了很好的水溶性。在2h内累积溶出度可达65%以上,溶出速率显著提高。 Objective: Prepare the solid dispersions ofpioglitazone Hydrochloride (PGH) by the freeze-drying method to enhance the dissolution rate of the drug. Methods: The solid dispersions of PGH have been prepared with carrier and aeidifier, then chose the optimal materials and the ratio by the dissolution rate data. Conclusion: The dissolution rate improved to the 65% during 2h, when used HPMC as the carriers, TA as the acdifier and the ratio of PGH: HPMC: TAwas 1:1:10% in this solid dispersion system. The dissolution rate of the drug has been increased significantly.
出处 《大众科技》 2015年第12期37-38,51,共3页 Popular Science & Technology
关键词 盐酸吡咯列酮 固体分散体 体外溶出度 Pioglitazone hydrochloride solid dispersion in vitro dissolution
  • 相关文献

参考文献6

  • 1杨小洁,温晨东.盐酸吡格列酮治疗2型糖尿病临床研究[J].临床医药实践,2003,12(2):92-94. 被引量:4
  • 2POKHARKAR V, KUTWAL M,MANDPE L.Pioglitazone solid dispersion system prepared by spray drying method: in vitro and in vivo evaluation[J].PDAJ Pharm Sci Technol, 2013,67(1):23-34.
  • 3KHAN S,BATCHELOR H,HANSON P, et al.Dissolution rate enhancement in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphame- thoxazole solid dispersions[J].Drug Dev Ind Pharm,2013, 39(5):704-715.
  • 4郭波红,黄嘉敏,李晓芳,金描真.头孢地尼-聚乙烯吡咯烷酮固体分散体的制备[J].医药导报,2013,32(8):1072-1075. 被引量:9
  • 5SIEPE S,LUECKEL B,KRAMER A, et al.Strategies for design of hydrophilic matrix tablets with conlrolled microenvironmental pH[J].Int J Pharm,2006,316(1-2): 14-20.
  • 6TRAN TT, TRAN PH,LEE BJ.Dissolution-modulating mechanism of alkalizers and polymers in a nanoetrmlsifying solid dispersion containing ionizable and poorly water-soluble drug[J].Eur J Pharm Biopharm,2009,72(1):83-90.

二级参考文献9

  • 1DAVID R, GUAY P. Ceofdinir : and advanced-generation, bro- adspeclrumoral eephalosporin [ J ]. Clin Ther, 2002,24 ( 4 ) : 473 -489.
  • 2PERRY C M,SCOTr L J. Cefdinir:a review of its use in the management of mild-to-moderate bacterial infections [ J ]. Drugs, 2004,64 ( 13 ) : 1433-1464.
  • 3ALEEM O, KUCHEKAR B, PORE Y,et al. Effect of β-cyclo- dextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir [J]. J Pharm Biomed Ana,2008,47(3):535-540.
  • 4KARAVAS E, GEORGARAKIS E, SIGALAS M P, et al. In- vestigation of the release mechanism of a sparingly water- soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions [ J~. Eur J Pharm Biopharm,2007, 66 ( 3 ) :334-347.
  • 5LIU H, WANG P, ZHANG X, et al. Effects of extrusion pro-cess parameters on the dissolution behavior of indomethacin in Eudragit E PO solid dispersions [ J ]. Int J Pharm, 2010, 383 (1/2) : 161-169.
  • 6何丹,杨林,范琦.丹参酮ⅡA固体分散体的制备及溶出度考察[J].中国医院药学杂志,2009,29(8):649-651. 被引量:9
  • 7林燕.头孢地尼的国内外临床应用进展[J].中国药房,2010,21(4):382-384. 被引量:12
  • 8巫剑峰,邱佩斯,陈彦雯,陈海南,李沙.丹参提取物固体分散体的制备与溶出特性[J].中国医院药学杂志,2010,30(11):900-905. 被引量:8
  • 9周永健,边颖,蔡毅.第三代口服头孢菌素——头孢地尼[J].天津药学,2003,15(2):66-68. 被引量:22

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部